BeyondSpring Inc. (NASDAQ: BYSI)
$1.6800
+0.0300 ( +0.30% ) 7.2K
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.
Market Data
Open
$1.6800
Previous close
$1.6500
Volume
7.2K
Market cap
$68.90M
Day range
$1.6500 - $1.7200
52 week range
$0.8200 - $4.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Jan 03, 2025 |
| 3 | Insider transactions | 1 | Dec 31, 2024 |
| 3 | Insider transactions | 1 | Dec 31, 2024 |
| 3 | Insider transactions | 1 | Dec 31, 2024 |
| 3 | Insider transactions | 1 | Dec 31, 2024 |
| 3 | Insider transactions | 1 | Dec 31, 2024 |
| 3 | Insider transactions | 1 | Dec 31, 2024 |
| 3 | Insider transactions | 1 | Dec 31, 2024 |
| sc | Insider transactions | 1 | Nov 14, 2024 |
| 6-k | Form 6-K | 18 | Aug 29, 2024 |